Revakinagene Taroretcel: A Patient Guide
Revakinagene taroretcel is a gene therapy implant used in adults with idiopathic macular telangiectasia type 2, a rare eye disease that can slowly damage central vision. A retina specialist places a small capsule in the eye so it can release a protective protein over time. This is general information only and is not a substitute for advice from your eye doctor or pharmacist.
Revakinagene taroretcel is a one-time surgical eye implant that may help slow vision loss from macular telangiectasia type 2; it does not cure the disease or restore vision that is already lost. Ask your retina specialist whether it is appropriate for you and what follow-up you will need.
Key facts at a glance
- RxNorm
- 2708830
- Generic
- Revakinagene Taroretcel
- Class
- unclassified
- Brands
- Encelto
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 31, 2026. · Read our editorial policy